SNY - Sanofi

46.22
-0.250   -0.541%

Share volume: 4,046,675
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%
$46.47
-0.25
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
-3.02%
1 Month
-2.67%
3 Months
-6.68%
6 Months
-0.60%
1 Year
-21.86%
2 Year
-2.69%
Key data
Stock price
$46.22
P/E Ratio 
23.91
DAY RANGE
$45.94 - $46.46
EPS 
N/A
52 WEEK RANGE
$44.62 - $60.12
52 WEEK CHANGE
-$22.21
MARKET CAP 
142.744 B
YIELD 
3.62%
SHARES OUTSTANDING 
2.537 B
DIVIDEND
$2.0369
EX-DIVIDEND DATE
05-09-2024
NEXT EARNINGS DATE
07-24-2025
BETA 
0.18
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,637,275
AVERAGE 30 VOLUME 
$5,187,755
Company detail
CEO: Paul Hudson
Region: US
Website: sanofi.com
Employees: 91,600
IPO year: 2002
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation.

Recent news